Organogenesis Holdings (ORGO) Cash & Equivalents (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Cash & Equivalents of $91.4 million for Q1 2026, down 16.9% year-over-year from $110.0 million in Q1 2025, and down 2.46% quarter-over-quarter from $93.7 million in Q4 2025.
Organogenesis Holdings (ORGO) Cash & Equivalents (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Cash & Equivalents history runs 11 years deep, the most recent figure standing at $91.4 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 16.9% year-over-year to $91.4 million; the TTM figure through Mar 2026 stood at $91.4 million (down 16.9% YoY), while the FY2025 annual figure was $93.7 million, down 30.9% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $91.4 million, down from $93.7 million in the prior quarter.
- The five-year high for Cash & Equivalents was $135.6 million in Q4 2024, with the low at $63.7 million in Q3 2025.
- The 5-year median for Cash & Equivalents is $94.3 million (2024), against an average of $97.1 million.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 30.56% in 2024, then plunged 32.43% in 2025.
- Organogenesis Holdings' Cash & Equivalents stood at $102.5 million in 2022, then advanced by 1.33% to $103.8 million in 2023, then surged by 30.56% to $135.6 million in 2024, then plunged by 30.9% to $93.7 million in 2025, then decreased by 2.46% to $91.4 million in 2026.
- Business Quant data shows ORGO's Cash & Equivalents at $91.4 million in Q1 2026, $93.7 million in Q4 2025, and $63.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 164.00 Mn |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | 46.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.10 Mn |
| Mar 31, 2026 | 91.38 Mn |
| Dec 31, 2025 | 93.68 Mn |
| Sep 30, 2025 | 63.75 Mn |
| Jun 30, 2025 | 73.08 Mn |
| Mar 31, 2025 | 109.97 Mn |
| Dec 31, 2024 | 135.57 Mn |
| Sep 30, 2024 | 94.34 Mn |
| Jun 30, 2024 | 89.90 Mn |
| Mar 31, 2024 | 88.63 Mn |
| Dec 31, 2023 | 103.84 Mn |
| Sep 30, 2023 | 98.23 Mn |
| Jun 30, 2023 | 88.92 Mn |
| Mar 31, 2023 | 88.69 Mn |
| Dec 31, 2022 | 102.48 Mn |
| Sep 30, 2022 | 107.25 Mn |
| Jun 30, 2022 | 112.28 Mn |
| Mar 31, 2022 | 107.90 Mn |
| Dec 31, 2021 | 113.93 Mn |
| Dec 31, 2020 | 84.39 Mn |